Fusion Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
FUSN Fusion Pharmaceuticals Inc
RDUS Schnitzer Steel Industries Inc
ALEC Alector Inc
LZM Lifezone Metals Ltd
LMRMF Lomiko Metals Inc
SOXL Direxion Daily Semiconductor Bull 3X Shares
OXSQ Oxford Square Capital Corp
BAER Bridger Aerospace Group Holdings Inc
CMRA Comera Life Sciences Holdings Inc
SY So-Young International Inc

Health Care : Biotechnology | Small Cap Value
Based in Canada
Company profile

Fusion Pharmaceuticals Inc. is a clinical-stage oncology company. The Company is focused on developing radiopharmaceuticals as precision medicines. It has developed its Targeted Alpha Therapies (TAT), platform to enable it to connect alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha particle payloads to tumors. The TAT platform is underpinned by its ability to radiolabel various classes of targeting molecules, its research and insights into the underlying chemistry and biology of alpha emitting radiopharmaceuticals, its differentiated capabilities in target identification, candidate generation, manufacturing and supply chain, its Fast-Clear linker technology used in conjunction with antibody-based targeting molecules, and development of imaging agents. Its clinical portfolio includes FPI-2265, FPI-1434 and FPI-2059. FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer in a Phase 2 trial.

Day's Change
-0.155 (-6.09%)
B/A Size
Day's High
Day's Low

Today's volume of 23,055 shares is on pace to be in-line with FUSN's 10-day average volume of 28,131 shares.


Lightning eMotors stock rallies toward 1st gain in 6 days after deal to supply 6 electric shuttle buses to Vanderbilt University

8:27 am ET May 18, 2023 (MarketWatch)

Shares of Lightning eMotors Inc. (ZEV) rallied 5.1% in premarket trading Thursday, putting them on track to snap a five-day losing streak, after the electric vehicle maker said it will supply six electric shuttle buses to Vanderbilt University. The Lightning ZEV4 shuttles are expected to be delivered in the second quarter of 2023, for use by VandyRide, the university's intercampus transportation service. The electric shuttles are built on the General Motors Co.-based platform, and deliver up to 130 miles of range. "We are confident drivers, passengers and fleet managers will appreciate the electric performance, quiet ride and reduced maintenance, and of course, the environmental benefits of the Lightning ZEV4," said Jeremy Hiller, sales director for Eastern U.S. at Lighting eMotors. The stock had tumbled 35.6% amid a five-day losing streak through Wednesday, which was so far the longest such streak since the five-day stretch that ended Feb. 9, 2023. The stock has plunged 49.4% year to date through Wednesday, while the Global X Autonomous & Electric Vehicles exchange-traded fund (DRIV) has rallied 16.7% and the S&P 500 has gained 8.3%.

-Tomi Kilgore

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.


(END) Dow Jones Newswires

May 18, 2023 08:27 ET (12:27 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.